Waiting for approval letter from ethics committee Study for the therapeutic effect of probiotics combined with chemotherapy after gastric cancer surgery

Study for the therapeutic effect of probiotics combined with chemotherapy after gastric cancer surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900022538

Enrollment

Unknown

Registered

2019-04-16

Start date

2019-06-01

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative gastric cancer

Interventions

Group 2:Chemotherapy + Oral probiotics

Group 1:Chemotherapy only

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Informed consent; 2. Pathological diagnosis of gastric cancer, after gastrectomy; 3. Patients are generally in good condition, aged 18-70 years.

Exclusion criteria

Exclusion criteria: 1. Patients with severe heart, lung, kidney, liver dysfunction and metabolic diseases; 2. allergic to probiotics; 3. patients with immune diseases, unable to take orally or absorb digestive tract drugs or allergic to probiotics.

Design outcomes

Primary

Measure	Time frame
High throughput sequencing of feces ;	—

Countries

China

Contacts

Public ContactDeng Xiaorong

Second Affiliated Hospital of Nanchang University

dengxr77@163.com+86 13870889003

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026